OpGen, Inc. (OTC:OPGN – Get Free Report) shares passed above its fifty day moving average during trading on Tuesday . The stock has a fifty day moving average of $0.73 and traded as high as $5.03. OpGen shares last traded at $4.95, with a volume of 2,624 shares traded.
OpGen Price Performance
The company has a market capitalization of $49.85 million, a P/E ratio of -0.89 and a beta of -1.77. The business’s 50-day moving average price is $0.73 and its two-hundred day moving average price is $3.05.
About OpGen
OpGen, Inc, a precision medicine company, engages in developing and commercializing molecular microbiology solutions in the United States and internationally. Its product portfolio includes Acuitas AMR Gene Panel, an in vitro diagnostic (IVD) test for the detection and identification of various bacterial nucleic acids and genetic determinants of antimicrobial resistance (AMR) from bacterial colonies isolated from any specimen, as well as Curetis CE-IVD-marked polymerase chain reaction-based SARS-CoV-2 test kits.
Recommended Stories
- Five stocks we like better than OpGen
- Roth IRA Calculator: Calculate Your Potential Returns
- 3 Beaten-Down Stocks With Rebound Potential This Earnings Season
- How to trade penny stocks: A step-by-step guide
- Amazon Is One of the Clearest Buys If the Market Dips Again
- When to Sell a Stock for Profit or Loss
- CoreWeave’s Guidance Cut: A Buying Opportunity in Disguise?
Receive News & Ratings for OpGen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OpGen and related companies with MarketBeat.com's FREE daily email newsletter.
